Quellis Biosciences
Philadelphia
About Quellis Biosciences
Quellis Biosciences is dedicated to improving the lives of patients suffering from serious rare diseases by developing next-generation antibody therapies that deliver value by improving patient outcomes.Quellis was founded to deliver best-in-class therapies to patients suffering serious rare diseases – and underserved by current treatment options.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $17.0M
- Funding stage: M&A
- Last round: Series A (Dec 2019)
- Website: quellisbio.com
- Phone: (267) 760-4066
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/quellis-biosciences-123484 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.